Students at the University of Colorado at Boulder will participate in a study to determine whether the COVID-19 vaccine developed by Moderna prevents transmission of the coronavirus.
The study began at the university last week when 11 students were vaccinated against the coronavirus. About 700 students from the school will participate in the five-month study, according to a press release.
The aim of the study is to find out whether Moderna’s vaccine will prevent a person from becoming infected after being vaccinated and whether the vaccine will also prevent the virus from spreading to others. Clinical trials have mainly focused on how the vaccine protects people who have received the vaccine from moderate and severe illness, the latter of which can lead to hospitalization and death.
A federal study released on Monday found that vaccines developed by both Moderna and Pfizer are effective in preventing coronavirus infection in people vaccinated, suggesting that transmission is rare.
He also found that with two doses, injections prevented 90% of infections. And after one dose, the vaccines prevented 80% of infections, according to the report released by the Centers for Disease Control and Prevention.
A person is considered fully protected two weeks after their second dose of Moderna and Pfizer vaccines.
The CU Boulder study will also examine the extent to which Moderna’s vaccine prevents asymptomatic transmission of the virus, which occurs when a person is infected but does not have symptoms, according to the press release.
“Until we know how well vaccination protects you from infecting others, it’s hard to know how well to relax restrictions and fully reopen things,” said co-principal investigator Dr Brian Stauffer. , chief of cardiology at Denver Health Medical Center, in a statement.
In the study, researchers will vaccinate half of the students first, waiting to vaccinate the other half four months later. Students will be tested twice a week using CU Boulder’s Saliva Monitoring Program. If a person tests positive, their close contacts will be asked to collect nasal swabs daily for 14 days and blood samples to determine if they are also infected, according to the press release.
A total of 12,000 students from 21 universities will participate in the study, which is being led by the COVID-19 Prevention Network at the Fred Hutchinson Cancer Research Center in Seattle. The ages of participants range from 18 to 26, according to the release.
Subscribe to the bi-monthly newsletter to receive health news straight to your inbox.